Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Optic Nerve Diseases × Clear all

NCT01331616 2021-12-09

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Phase EARLY_PHASE1 Withdrawn

Glioblastoma, Optic Nerve Diseases